The subregion with the highest annual prevalence of use of "ecstasy" globally is Australia and New Zealand where "ecstasy" is mostly used in capsules and crystal form.

• In Australia, after a decline in the use and availability of "ecstasy" since the onset of the COVID-19 pandemic, use and availability have started to increase again in 2023, but did not reach pre-2020 levels, especially in terms of capsules use prevalence.
• In New Zealand, the use of "ecstasy" has remained relatively stable at a relatively high level since 2020 apart from a temporary drop coinciding with the COVID-19 pandemic.